Rhinology
On demand events
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions
In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.
DMSc, MD
Vibeke Backer +1 more
Learning objectives
- Understand the link between type 2 inflammation and disease severity and relapse of disease in patients with CRSwNP in CRSwNP
- Review and critique existing criteria for defining and measuring disease control in CRSwNP, including the role of patient-reported control
- Examine phase 3, ITC, and H2H evidence of approved biologic efficacy and safety for patients with severe/uncontrolled CRSwNP
- Discuss strategies for developing internationally validated measures of CRSwNP severity and control
Description
Leading global experts, Prof. Sietze Reitsma and Prof. Vibeke Backer dissect the intricate immunological pathways that drive the most challenging forms of CRSwNP, providing a foundational understanding of severe and uncontrolled disease pathophysiology and guide through approved biologic therapies offering a strategic framework for achieving and maintaining optimal, long-term disease management.
Tags
About these experts
